Opal V2C® System Precision Motion

In the realm of healthcare, mobility stands as a fundamental capability, enabling individuals to safely and autonomously perform their daily tasks. Its significance becomes evident when impaired mobility enters the picture, potentially resulting in a cascade of consequences: inactivity, loss of independence, a reduced quality of life, and even untimely mortality. Remarkably, independent mobility consistently ranks as a paramount concern for patients, highlighting its central role in well-being.

While clinical scales have historically served as tools to assess the severity of nervous system disorders, they are not without their limitations. These traditional scales are often critiqued for their restricted sensitivity, unreliable interrater consistency, and imprecision of their outcomes, notably affecting the progress of clinical trials, especially those focused on rare diseases.

In stark contrast, the emergence of digital assessments for gait and balance has ushered in a new era of precision. These assessments offer a clear and accurate gauge of disease severity, empowering researchers with more meaningful metrics for tracking changes over time. Evidence from research underscores the superiority of gait and balance assessments in detecting early indications of disease, revolutionizing the way we approach healthcare evaluation.

Learn how your teams can transform endpoint measurement in clinical trials by integrating wearable sensors to establish objective digital mobility endpoints.